Trial intelligence / Profile preview

Pharmacodynamic Effects of Prednisolone on Whole Blood Protein and Gene Expression in Rheumatoid Arthritis

2005-000902-30Phase 4Completed

Sponsor
GSK
Start
Aug 2005
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of prednisolone in rheumatoid arthritis (RA), sponsored by GSK. Primary endpoint: DAS28 score. Started Aug 2005; status: completed.

02

Drugs

prednisolone
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on 2005-000902-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000902-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call